Miocardiopatía Restrictiva secundaria a Síndrome Hipereosinofílico

1024x768 Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin:0cm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:minor-fareast; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi;} La Miocardiopatia restrictiva secundaria al Sindrome Hiperosinofilico (SHE) es raro, constituye un grupo de enfermedades caracterizadas por una sobreproduccion de eosinofilos, con el secundario dano de multiples organos provocado por la infiltracion eosinofilica y la liberacion de mediadores. Dividido en tres fases la miocarditis eosinofilica es la mayor causa de morbimortalidad y la Miocardiopatia restrictiva la fase final del cuadro, la que se corresponde con la paciente que presentamos. Palabras clave: Sindrome Hiperosinofilico, miocarditis eosinofilica. _________________________________________________________________________________________________________ ABSTRACT 1024x768 Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin:0cm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:minor-fareast; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi;} Restrictive cardiomyopathy secondary to Hyperosinophilic Syndrome (SHE) is rare; it constitutes a group of diseases characterized by an overproduction of eosinophils, with secondary damage of multiple organs caused by eosinophilic infiltration and the release of mediators. Divided into three phases, eosinophilic myocarditis is divided into three phases and it is the major cause of morbidity and mortality and restrictive cardiomyopathy is the final phase of the condition, which it corresponds to the patient presented.